JP Patent

JP7177314B2 — セフトロザン抗生物質組成物

Assigned to メルク・シャープ・アンド・ドーム・エルエルシー · Expires 2022-11-24 · 3y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP7177314B2
Jurisdiction: JP
Classification: —
Expires: 2022-11-24
Drug substance claim: No
Drug product claim: No
Assignee: メルク・シャープ・アンド・ドーム・エルエルシー
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.